Claudia examines Mental Health and Covid and a large new Lancet Psychiatry study showing that one in three people develop anxiety, depression or a neurological problem in the six months after they were ill with the virus. Ten years on from the Fukushima nuclear power plant disaster in Japan.
Wellbeing during the Covid Pandemic and how Art and gardening can help the stress and strain.
Professor Jun Shigemura discusses whether the unseen threat of exposure to radiation can teach us anything about dealing with the hidden threat of the current Covid-19 virus.
A report from Nigeria on how some people with fractures may turn to the traditional bonesetter to get their bones mended. Charles Mgbolu reports from Lagos. And diagnosing concussion: how a team at the University of Birmingham in the UK has developed a saliva test which can detect whether someone with a bang on the head during sport can safely return to the game.
Professor Tony Belli explains the science behind the test. Plus Claudia’s studio guest is Graham Easton, Professor of Clinical Communication Skills at Barts and the London Medical School.
Presenter: Claudia Hammond Producer: Erika Wright
Contributors to this story were the BBC Health Check Team along with our own research and identified contributors.
(Picture: A traditional Japanese kite, bearing messages of hope by children living in Fukushima prefecture, is flown over the Great East Japan Earthquake and Nuclear Disaster Memorial Museum in Futaba town on the eve of the 10th anniversary of the disaster. Photo credit: Kazuhiro Nogi/AFP/Getty Images.)
Read the Discovery report Lithium is it really Chile’s white gold?
Mental health stigma
Many people have struggled with their mental health during the pandemic, but still don’t always feel free to discuss it, especially at work.
Did SARS-Covid 19 originate in bats?
Recent evidence from the Institut Pasteur has identified several novel coronaviruses with similarities to the current coronavirus in bats.
Professor Marc Eliot spoke to Roland Pease about how this research could give us a better idea of where Covid-19 came from.
Molnupiravir? Are there side effects?
Molnupiravir, an antiviral pill being developed by Merck & Co., has been touted as a potential game-changer in the fight against Covid-19.